Featured Firms
Presented by BigVoodoo
As Amgen's patent infringement trial against Transkaryotic Therapies drags into its third month, central themes are emerging. To win, Transkaryotic Therapies must prove that its enzyme-fighting drug doesn't infringe Amgen's patents or that the patents are invalid based on flaws in the application process. The landmark case could clarify intellectual property standards or rewrite the standard for process patents.
July 31, 2000 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS